Envestnet Asset Management Inc Anika Therapeutics, Inc. Transaction History

Envestnet Asset Management Inc

$302 Billion
Q4 2024

A detailed history of Envestnet Asset Management Inc transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 69,077 shares of ANIK stock, worth $1.23 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

69,077

Previous 70,119 1.49%

Holding current value

$1.23 Million

Previous $1.73 Million 34.32%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$16.04 - $25.53 $16,713 - $26,602	-1,042 Reduced 1.49%	69,077 $1.14 Million
Q3 2024 Nov 06, 2024	SELL	$24.25 - $28.75 $141,450 - $167,698	-5,833 Reduced 7.68%	70,119 $1.73 Million
Q2 2024 Aug 08, 2024	BUY	$24.57 - $28.47 $5,208 - $6,035	212 Added 0.28%	75,952 $1.92 Million
Q1 2024 May 13, 2024	SELL	$21.95 - $26.42 $47,412 - $57,067	-2,160 Reduced 2.77%	75,740 $1.92 Million
Q4 2023 Feb 13, 2024	BUY	$18.47 - $23.3 $35,056 - $44,223	1,898 Added 2.5%	77,900 $1.77 Million
Q3 2023 Nov 13, 2023	BUY	$16.98 - $26.1 $1.29 Million - $1.98 Million	76,002 New	76,002 $1.42 Million
Q3 2022 Nov 10, 2022	BUY	$21.74 - $24.68 $86,938 - $98,695	3,999 Added 40.62%	13,844 $329,000
Q2 2022 Aug 03, 2022	BUY	$20.4 - $25.53 $200,838 - $251,342	9,845 New	9,845 $220,000
Q1 2021 May 04, 2021	SELL	$32.49 - $45.96 $978,761 - $1.38 Million	-30,125 Closed	0 $0
Q4 2020 Feb 02, 2021	BUY	$32.59 - $45.26 $112,761 - $156,599	3,460 Added 12.98%	30,125 $1.36 Million
Q3 2020 Oct 09, 2020	BUY	$32.56 - $38.57 $147,594 - $174,837	4,533 Added 20.48%	26,665 $944,000
Q2 2020 Jul 08, 2020	BUY	$27.83 - $37.73 $36,958 - $50,105	1,328 Added 6.38%	22,132 $835,000
Q1 2020 Apr 23, 2020	BUY	$22.38 - $54.06 $32,518 - $78,549	1,453 Added 7.51%	20,804 $601,000
Q4 2019 Feb 11, 2020	BUY	$51.85 - $73.36 $102,611 - $145,179	1,979 Added 11.39%	19,351 $1 Million
Q3 2019 Oct 17, 2019	SELL	$40.05 - $57.47 $60,475 - $86,779	-1,510 Reduced 8.0%	17,372 $954,000
Q2 2019 Aug 02, 2019	BUY	$30.3 - $41.14 $35,541 - $48,257	1,173 Added 6.62%	18,882 $767,000
Q1 2019 May 10, 2019	BUY	$29.37 - $40.49 $182,886 - $252,131	6,227 Added 54.23%	17,709 $536,000
Q4 2018 Feb 13, 2019	BUY	$30.16 - $43.0 $346,297 - $493,726	11,482 New	11,482 $386,000
Q3 2018 Nov 14, 2018	SELL	$32.83 - $42.51 $31,188 - $40,384	-950 Closed	0 $0
Q2 2018 Aug 10, 2018	SELL	$28.77 - $48.27 $75,003 - $125,839	-2,607 Reduced 73.29%	950 $30,000
Q1 2018 May 09, 2018	SELL	$49.22 - $68.43 $69,203 - $96,212	-1,406 Reduced 28.33%	3,557 $173,000
Q4 2017 Feb 20, 2018	BUY	$52.14 - $59.94 $625 - $719	12 Added 0.24%	4,963 $267,000
Q3 2017 Nov 13, 2017	BUY	$51.16 - $58.21 $17,087 - $19,442	334 Added 7.23%	4,951 $287,000
Q2 2017 Aug 14, 2017	BUY	N/A	4,617	4,617 $228,000

Others Institutions Holding ANIK

# of Institutions

113

Shares Held

10.8M

Call Options Held

200

Put Options Held

100

View Full List

About Anika Therapeutics, Inc.

Ticker ANIK
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,599,900
Market Cap $259M
Description
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...

More about ANIK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Account

Envestnet Asset Management Inc Anika Therapeutics, Inc. Transaction History